Z29.13

Clinical Causes: Pregnancy in an Rh-negative woman with an Rh-positive fetus History of previous Rh-positive pregnancies or transfusions Medical recommendation for Rh immune globulin injections during pregnancy

Key Symptoms: Typically no symptoms are associated with the prophylactic treatment itself Potential side effects may include allergic reactions such as rash, itching, or swelling Rarely, more severe reactions like difficulty breathing or anaphylaxis

Diagnosis Path: The diagnosis for administering Rho(D) immune globulin involves confirming the Rh status of both mother and fetus. Blood tests are performed to determine whether the mother is Rh-negative and the fetus is Rh-positive. This testing guides the decision to administer the immune globulin and ensures the treatment is appropriate. Typically, the treatment is recommended during pregnancy around the 28th week and within 72 hours after delivery if the baby is confirmed to be Rh-positive.

Treatment Protocols: The primary treatment for Rh incompatibility involves administering Rho(D) immune globulin, a blood product that contains antibodies against Rh-positive blood cells. This injection is generally given in the following situations: - **During pregnancy:** Usually at around 28 weeks gestation to prevent sensitization - **After delivery:** If the newborn is Rh-positive, to prevent the mother from developing an immune response against future pregnancies - **After potential exposure:** If the mother experiences trauma or bleeding during pregnancy, the injection can help prevent immune sensitization. The procedure involves a healthcare professional giving an injection of Rho(D) immune globulin, which works by targeting and eliminating fetal Rh-positive blood cells in the mother's bloodstream before her immune system can respond. This helps to prevent hemolytic disease of the fetus and newborn in subsequent pregnancies.